These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37441734)

  • 21. Real-World Data Analytics Fit for Regulatory Decision-Making.
    Schneeweiss S; Glynn RJ
    Am J Law Med; 2018 May; 44(2-3):197-217. PubMed ID: 30106649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements.
    Sievers H; Joos A; Hiligsmann M
    Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pushing the boundaries of evaluation, diffusion, and use of medical devices in Europe: Insights from the COMED project.
    Torbica A; Tarricone R; Schreyögg J; Drummond M
    Health Econ; 2022 Sep; 31 Suppl 1():1-9. PubMed ID: 36068719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Most important barriers and facilitators of HTA usage in decision-making in Europe.
    Cheung KL; Evers SMAA; De Vries H; Levy P; Pokhrel S; Jones T; Danner M; Wentlandt J; Knufinke L; Mayer S; Hiligsmann M
    Expert Rev Pharmacoecon Outcomes Res; 2018 Jun; 18(3):297-304. PubMed ID: 29303374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Considerations for the Use of Machine Learning Extracted Real-World Data to Support Evidence Generation: A Research-Centric Evaluation Framework.
    Estevez M; Benedum CM; Jiang C; Cohen AB; Phadke S; Sarkar S; Bozkurt S
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancing the development of real-world data for healthcare research in China: challenges and opportunities.
    Zhong J; Zhang J; Fang H; Liu L; Xie J; Wu E
    BMJ Open; 2022 Jul; 12(7):e063139. PubMed ID: 35906059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electronic Health Records at People's Hands Across Europe: The InteropEHRate Protocols.
    Kiourtis A; Mavrogiorgou A; Mavrogiorgos K; Kyriazis D; Graziani A; Symvoulidis C; Bella G; Bocca S; Torelli F
    Stud Health Technol Inform; 2022 Nov; 299():145-150. PubMed ID: 36325855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.
    Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B
    JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The European cross-border health data exchange roadmap: Case study in the Italian setting.
    Nalin M; Baroni I; Faiella G; Romano M; Matrisciano F; Gelenbe E; Martinez DM; Dumortier J; Natsiavas P; Votis K; Koutkias V; Tzovaras D; Clemente F
    J Biomed Inform; 2019 Jun; 94():103183. PubMed ID: 31009760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic Regulatory Assessment: evolving the European Regulatory Framework for the Benefit of Patients and Public Health-an EFPIA View.
    Herrero-Martinez E; Hussain N; Roux NL; MacDonald J; Mayer M; Palacios R; Kühler TC
    Clin Ther; 2022 Jan; 44(1):132-138. PubMed ID: 34848082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making.
    Bakker E; Plueschke K; Jonker CJ; Kurz X; Starokozhko V; Mol PGM
    Clin Pharmacol Ther; 2023 Jan; 113(1):135-151. PubMed ID: 36254408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries.
    Tachkov K; Zemplenyi A; Kamusheva M; Dimitrova M; Siirtola P; Pontén J; Nemeth B; Kalo Z; Petrova G
    Front Public Health; 2022; 10():921226. PubMed ID: 35910914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artificial Intelligence and Machine Learning Applied at the Point of Care.
    Angehrn Z; Haldna L; Zandvliet AS; Gil Berglund E; Zeeuw J; Amzal B; Cheung SYA; Polasek TM; Pfister M; Kerbusch T; Heckman NM
    Front Pharmacol; 2020; 11():759. PubMed ID: 32625083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using Real-World Data in the Health Technology Assessment of Pharmaceuticals: Strengths, Difficulties, and a Pragmatic Way Forward.
    Akehurst R; Murphy LA; Solà-Morales O; Cunningham D; Mestre-Ferrandiz J; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):11-19. PubMed ID: 36706952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial designs using real-world data: The changing landscape of the regulatory approval process.
    Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.
    Moseley J; Vamvakas S; Berntgen M; Cave A; Kurz X; Arlett P; Acha V; Bennett S; Cohet C; Corriol-Rohou S; Du Four E; Lamoril C; Langeneckert A; Koban M; Pasté M; Sandler S; Van Baelen K; Cangini A; García S; Obach M; Gimenez Garcia E; Varela Lema L; Jauhonen HM; Rannanheimo P; Morrison D; Van De Casteele M; Strömgren A; Viberg A; Makady A; Guilhaume C
    Br J Clin Pharmacol; 2020 Jun; 86(6):1034-1051. PubMed ID: 32162368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.